Corcept amends bylaws to strengthen director nomination and meeting rules

CORCEPT THERAPEUTICS INC

Board can postpone, reschedule or cancel annual meetings even after notice has been sent to stockholders.
Enhanced requirements for stockholder nominations and proposals; must comply with Rule 14a-19 and attend the meeting.
Proxy card color rule: white cards reserved for Board; any other solicitation must use a different color.
Eliminated requirement to make stockholder list available at meetings, aligning with recent Delaware law changes.
Amendments effective December 5, 2023; govern meeting procedures and proxy solicitation mechanics.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CORCEPT THERAPEUTICS INC: Amended and restated bylaws to allow postponement/rescheduling/cancellation of annual meetings, enhance director nomination and business proposal requirements, and address proxy solicitation mechanics (effective 2023-12-05).

Change: bylaw amendment
Effective: 2023-12-05

Exact text from the filing

On December 5, 2023, the Board of Directors (the “Board”) of Corcept Therapeutics Incorporated (the “Company”) approved and adopted an amendment and restatement of the Company’s amended and restated bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective as of December 5, 2023.

View on SEC.gov

Browse all governance changes →

CORCEPT THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001193125-23-292621

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.